Cargando…
Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study
AIMS: Although the exact factors promoting disease progression in COVID-19 are not fully elucidated, unregulated activation of the complement system (CS) seems to play a crucial role in the pathogenesis of acute lung injury (ALI) induced by SARS-CoV-2. In particular, the lectin pathway (LP) has been...
Autores principales: | Charitos, Panteleimon, Heijnen, Ingmar A. F. M., Egli, Adrian, Bassetti, Stefano, Trendelenburg, Marten, Osthoff, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581394/ https://www.ncbi.nlm.nih.gov/pubmed/34777382 http://dx.doi.org/10.3389/fimmu.2021.765330 |
Ejemplares similares
-
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
por: Urwyler, Pascal, et al.
Publicado: (2020) -
Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study
por: Bruni, Flavio, et al.
Publicado: (2022) -
Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases
por: Vogt, Severin, et al.
Publicado: (2020) -
The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor
por: Panagiotou, Anneza, et al.
Publicado: (2018) -
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial
por: Urwyler, Pascal, et al.
Publicado: (2023)